Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 2854-2862, June 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saitoh, O.
Right arrow Articles by Fukuda, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saitoh, O.
Right arrow Articles by Fukuda, M.

Expression of Aberrant O-Glycans Attached to Leukosialin in Differentiation-deficient HL-60 Cells1

Osamu Saitoh, Robert E. Gallagher and Minoru Fukuda2

La Jolla Cancer Research Foundation, Cancer Research Center, La Jolla, California 92037 [O. S., M. F.], and Montefiore Medical Center, Bronx, New York 10467 [R. E. G.]

Promyelocytic leukemia HL-60 cells can be induced to differentiate into granulocytic cells by various agents including retinoic acid (RA), dimethyl sulfoxide, and 6-thioguanine (6-TG). Although the induced cells are no longer capable of proliferation, a few cells continue to divide in the presence of inducers, and these cells are resistant to terminal differentiation by these inducers (R. E. Gallagher, D. A. Giangiulio, C-S. Chang, C. J. Glover, and R. L. Felsted, Blood, 68: 1402–1406, 1986).

The present study examined the structures of O-glycans attached to leukosialin, a major sialoglycoprotein in HL-60 cells, and the activities of glycosyltransferases involved in O-glycan synthesis. Leukosialin from RA-resistant and 6-TG-resistant HL-60 sublines migrated much more slowly than those from wild-type HL-60 cells when applied to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The dimethyl sulfoxide-resistant HL-60 subline, on the other hand, expressed leukosialin with a molecular weight similar to wild-type HL-60 cells. RA-resistant and 6-TG-resistant HL-60 cells were found to express a significant amount of tetrasaccharides that contain no sialic acid residue, while wild-type HL-60 cells expressed mainly disialosyl hexasaccharides and contained no detectable amount of asialo-oligosaccharides. Furthermore, wild-type HL-60 cells treated with the inducers for 4 days were found to express the same saccharides present in untreated wild-type HL-60 cells, indicating that the altered O-glycans present in RA and 6-TG sublines were not caused by a direct effect of these agents but rather are intrinsically unique to these sublines.

To better understand the mechanisms underlying the differences in O-glycans, the activities of four sialyltransferases were measured: Galß1->3GalNAc{alpha}2->3sialyltransferase, Galß1->4(3)GlcNAc{alpha}2->3sialyltransferase, Galß1->4GlcNAc{alpha}2->6sialyltransferase, and GalN-Ac{alpha}2->6sialyltransferase. Among them, Galß1->3GalNAc{alpha}2->3sialyltransferase and Galß1->4(3)GlcNAc{alpha}2->3sialyltransferase were much lower in the RA- or 6-TG-resistant HL-60 subline than in wild-type HL-60 cells. These findings indicate that the differences in O-glycans are due to the differences in {alpha}2->3sialyltransferase activities. These results strongly suggest that O-glycans associated with leukosialin may play some role in HL-60 cell differentiation.

1 This work was supported by Grant R01 CA33895 from the National Cancer Institute.

2 To whom requests for reprints should be addressed, at La Jolla Cancer Research Foundation, 10901 North Torrey Pines Road, La Jolla, CA 92037.

Received 1/ 2/91. Accepted 3/22/91.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
M. Clement, J. Rocher, G. Loirand, and J. Le Pendu
Expression of sialyl-Tn epitopes on {beta}1 integrin alters epithelial cell phenotype, proliferation and haptotaxis
J. Cell Sci., October 1, 2004; 117(21): 5059 - 5069.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. A. Carlow, S. Y. Corbel, M. J. Williams, and H. J. Ziltener
IL-2, -4, and -15 Differentially Regulate O-Glycan Branching and P-Selectin Ligand Formation in Activated CD8 T Cells
J. Immunol., December 15, 2001; 167(12): 6841 - 6848.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. H. Live, L. J. Williams, S. D. Kuduk, J. B. Schwarz, P. W. Glunz, X.-T. Chen, D. Sames, R. A. Kumar, and S. J. Danishefsky
Probing cell-surface architecture through synthesis: An NMR-determined structural motif for tumor-associated mucins
PNAS, March 30, 1999; 96(7): 3489 - 3493.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.